Does Blue Cross Blue Shield of Massachusetts cover Wegovy and Zepbound?
The short answer
Blue Cross Blue Shield of Massachusetts doesn't cover Wegovy or Zepbound as standard. It told accounts and brokers that Wegovy, Saxenda and Zepbound are excluded from coverage as each plan renews on or after January 1, 2026. Employer groups with more than 100 employees can add weight-loss drug coverage for an additional cost. Ozempic and Mounjaro stay covered for type 2 diabetes.
Key takeaways
- Wegovy, Saxenda and Zepbound are excluded when your Massachusetts plan renews on or after January 1, 2026.
- Employer groups with more than 100 employees can add weight-loss drug coverage for an additional cost, so ask your benefits team.
- Ozempic and Mounjaro stay covered for type 2 diabetes with prior authorization, not for weight loss.
- An appeal argues you meet a plan's criteria. Under an exclusion there are none to meet, so ask about exceptions in writing.
- If your commercial plan doesn't cover Zepbound, Lilly's card sets the single-dose pen at $499 a month.
What the published policies say
Blue Cross Blue Shield of Massachusetts: Mounjaro commercial covered with pa
Blue Cross Blue Shield of Massachusetts continues to cover Mounjaro for type 2 diabetes. Prior authorization is required, including a documented diagnosis of type 2 diabetes; it is not covered for weight loss.
- Prior authorization required
- Documented diagnosis of type 2 diabetes
This includes medications such as Ozempic, Mounjaro, Trulicity, and others, which aren’t approved for weight loss. These medications will continue to require prior authorization, including a documented diagnosis of type 2 diabetes.
Blue Cross Blue Shield of Massachusetts: Ozempic commercial covered with pa
Blue Cross Blue Shield of Massachusetts continues to cover Ozempic for type 2 diabetes. Prior authorization is required, including a documented diagnosis of type 2 diabetes; it is not covered for weight loss.
- Prior authorization required
- Documented diagnosis of type 2 diabetes
This includes medications such as Ozempic, Mounjaro, Trulicity, and others, which aren’t approved for weight loss. These medications will continue to require prior authorization, including a documented diagnosis of type 2 diabetes.
Blue Cross Blue Shield of Massachusetts: Saxenda commercial excluded benefit unless rider
Blue Cross Blue Shield of Massachusetts excludes Saxenda from standard coverage as each plan renews on or after January 1, 2026. Employer groups with more than 100 employees can pay extra to add weight-loss drug coverage; smaller groups cannot.
- Excluded on plan renewal from January 1, 2026
- Employers with more than 100 employees may add weight-loss drug coverage for an additional cost
On anniversary, starting January 1, 2026, Wegovy, Saxenda, and Zepbound will be excluded from coverage. ... Employer groups with more than 100 employees have the option of adding coverage for weight-loss drugs for an additional cost.
Blue Cross Blue Shield of Massachusetts: Wegovy commercial excluded benefit unless rider
Blue Cross Blue Shield of Massachusetts excludes Wegovy from standard coverage as each plan renews on or after January 1, 2026. Employer groups with more than 100 employees can pay extra to add weight-loss drug coverage; smaller groups cannot.
- Excluded on plan renewal from January 1, 2026
- Employers with more than 100 employees may add weight-loss drug coverage for an additional cost
On anniversary, starting January 1, 2026, Wegovy, Saxenda, and Zepbound will be excluded from coverage. ... Employer groups with more than 100 employees have the option of adding coverage for weight-loss drugs for an additional cost.
Blue Cross Blue Shield of Massachusetts: Zepbound commercial excluded benefit unless rider
Blue Cross Blue Shield of Massachusetts excludes Zepbound from standard coverage as each plan renews on or after January 1, 2026. Employer groups with more than 100 employees can pay extra to add weight-loss drug coverage; smaller groups cannot.
- Excluded on plan renewal from January 1, 2026
- Employers with more than 100 employees may add weight-loss drug coverage for an additional cost
On anniversary, starting January 1, 2026, Wegovy, Saxenda, and Zepbound will be excluded from coverage. ... Employer groups with more than 100 employees have the option of adding coverage for weight-loss drugs for an additional cost.
Policies differ between plans from the same insurer and change during the year. Your own plan documents decide.
Blue Cross Blue Shield of Massachusetts is the clearest “no” among the insurers we track. Its position is set out in a document written for employer accounts and brokers, “GLP-1 Coverage: Frequently Asked Questions.” It was written ahead of the change, so it speaks in the future tense about a rule that has since taken effect.
What the document says
The key sentence: “On anniversary, starting January 1, 2026, Wegovy, Saxenda, and Zepbound will be excluded from coverage.”
“On anniversary” means the exclusion arrives when each plan renews, not on one date for everyone. A plan that renewed on January 1, 2026 lost the coverage then. A plan with a later renewal date kept it until that date. If you’re not sure whether your plan has reached its 2026 renewal, your benefits team can tell you the date.
The employer opt-in
The same document leaves one door open: “Employer groups with more than 100 employees have the option of adding coverage for weight-loss drugs for an additional cost.”
That means two things:
- If you work for a larger employer, coverage is your employer’s choice. Ask your benefits team directly whether they added it, and if not, whether they’ll consider it at the next renewal.
- If your employer group has 100 employees or fewer, the option isn’t available to it.
The document we hold doesn’t set out the clinical criteria that apply where an employer has added the coverage.
Ozempic and Mounjaro are still covered for diabetes
The exclusion is aimed at the medicines approved for weight loss. For the diabetes medicines, the FAQ says: “These medications will continue to require prior authorization, including a documented diagnosis of type 2 diabetes.” It names Ozempic, Mounjaro and Trulicity.
So Ozempic and Mounjaro remain covered with prior authorization (the plan’s approval before it pays) for people with type 2 diabetes. They aren’t a covered route for weight loss.
What to do if you are affected
Ask whether your employer added the coverage. Under this policy, that’s the only route to plan coverage of Wegovy, Zepbound or Saxenda for weight loss.
Ask your prescriber what the drug is being prescribed for. The document we hold addresses weight loss and type 2 diabetes. It doesn’t say how the plan treats requests for other approved uses, so ask the plan in writing if one applies to you.
Price the cash routes. If you have commercial insurance that doesn’t cover the drug, you may still qualify for the manufacturers’ offers. Lilly’s card sets the Zepbound single-dose pen at $499 a month for commercially insured people whose plan doesn’t cover it, and self-pay Zepbound starts at $299. Self-pay Wegovy starts at $149. The savings card page and the without-insurance guide compare them, and the cheapest path finder ranks them for your dose.
Know what an appeal can and can’t do. An appeal argues that you meet the plan’s criteria. If the drug is excluded from the benefit, there are no criteria to meet, and our appeal guide explains that difference. If you have the employer-added coverage and were denied, the appeal letter generator is the place to start.
The insurance guide shows how other insurers handle the same medicines.
Frequently asked questions
Does Blue Cross Blue Shield of Massachusetts cover Zepbound?
Not under standard coverage once your plan has renewed on or after January 1, 2026. The insurer's FAQ says Wegovy, Saxenda and Zepbound will be excluded from coverage on anniversary from that date. The exception is an employer group with more than 100 employees that has chosen to add weight-loss drug coverage for an additional cost.
When did my Blue Cross MA plan stop covering Wegovy?
On your plan's anniversary, meaning its renewal date, on or after January 1, 2026. Plans renew at different points in the year, so two members could have lost coverage months apart. Your employer's benefits team or the member number on your card can confirm your plan's renewal date.
Does Blue Cross Blue Shield of Massachusetts still cover Ozempic and Mounjaro?
Yes, for type 2 diabetes. The FAQ says medications such as Ozempic, Mounjaro and Trulicity will continue to require prior authorization, including a documented diagnosis of type 2 diabetes. It describes them as medicines that aren't approved for weight loss, so they aren't a covered route for weight management.
Can I appeal the Blue Cross MA exclusion of weight loss drugs?
An exclusion is a choice about what the plan covers, which is different from a denial for not meeting clinical criteria. You can still ask the plan for its exception process and your appeal rights in writing. Your employer is the more direct route: groups with more than 100 employees have the option of adding coverage.
Sources (5)
- 1.Blue Cross Blue Shield of Massachusetts: GLP-1 Coverage: Frequently Asked Questions
“This includes medications such as Ozempic, Mounjaro, Trulicity, and others, which aren’t approved for weight loss. These medications will continue to require prior authorization, including a documented diagnosis of type 2 diabetes.”
- 2.Blue Cross Blue Shield of Massachusetts: GLP-1 Coverage: Frequently Asked Questions
“On anniversary, starting January 1, 2026, Wegovy, Saxenda, and Zepbound will be excluded from coverage. ... Employer groups with more than 100 employees have the option of adding coverage for weight-loss drugs for an additional cost.”
- 3.
- 4.
- 5.
Related pages
- What insurance covers Wegovy, Zepbound and other GLP-1 medicines?
- How to appeal a Wegovy or Zepbound insurance denial
- Cheapest GLP-1 without insurance: Wegovy, Zepbound and the rest
- Zepbound savings card, plus the Wegovy, Ozempic and Mounjaro cards
- Appeal letter generator
- Does Blue Cross Blue Shield of Michigan cover Wegovy, Zepbound and Ozempic?
